Olajide, E., Alaba, B. (2023). Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study. Journal of Applied Veterinary Sciences, 8(2), 62-66. doi: 10.21608/javs.2023.142098.1204
Edward O. Olajide; Bukola A. Alaba. "Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study". Journal of Applied Veterinary Sciences, 8, 2, 2023, 62-66. doi: 10.21608/javs.2023.142098.1204
Olajide, E., Alaba, B. (2023). 'Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study', Journal of Applied Veterinary Sciences, 8(2), pp. 62-66. doi: 10.21608/javs.2023.142098.1204
Olajide, E., Alaba, B. Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study. Journal of Applied Veterinary Sciences, 2023; 8(2): 62-66. doi: 10.21608/javs.2023.142098.1204
Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study
Department of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria Present address: Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, 40506, USA
Receive Date: 24 December 2022,
Revise Date: 17 February 2023,
Accept Date: 28 February 2023
Abstract
Ulcerative lymphangitis, a bacterial infection primarily caused by Corynebacterium pseudotuberculosis is an important infectious disease of horses and ruminants affecting the cutaneous lymphatic vessels. Differential diagnosis of ulcerative lymphangitis include epizootic lymphangitis, a fungal infection, sporotrichosis caused by Sporothrix schenckii, pyoderma, and glanders. The aim of this study is to describe the successful management protocol of ulcerative lymphangitis in a stallion in Ibadan, Nigeria. A 12 year old Arewa stallion was presented in December 2019 with cutaneous lesions, ulcerated wounds, anorexia, and weight loss. The lesions were present around the limbs, chest, facial and abdominal regions. Based on case history, the client previously had a mare presenting similar conditions, and decided to manage the mare according to his knowledge. Due to the unresponsiveness of the mare to the protocol incorporated by the client, resulted in the death of the mare. Furthermore, the client reported that three months earlier, the stallion had previously been managed for cutaneous myiasis with forceful expulsion of worms from the skin and the administration of ivermectin. Based on clinical and laboratory examinations, the case was diagnosed as ulcerative lymphangitis. Therapeutic management protocol includes the use of levofloxacin, an antibiotic of the fluoroquinolone drug class, diclofenac, tetanus antitoxin, and supportive therapy. The management protocol proved successful, with the stallion recovering 3 weeks posttreatment.
ADDO, P.B. 1980. A review of epizootic lymphangitis and ulcerative lymphangitis in Nigeria: Misnomer or misdiagnosis. Bulletin of Animal Health and Production in Africa, 28, 103-107.
ADEYEFA C.A.O. 1983. Ulcerative Lymphangitis in Dongola Horses in Ibadan, Nigeria. Tropical Veterinarian 1(1): 58-60.
AL-MUBARAK, A.M., SHUAIB, Y. A., and ABU-SAMRA, M.T., 2013. Severe Corynebacterium pseudotuberculosis infection in a horse. Int. J. Vet. Sci. 2: 133-137.
DJABAROUTI, S., BOSELLI, E., ALLAOUCHICHE, B., BA, B., NGUYEN, A.T., GORDIEN, J.B., ET AL. 2004. Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J Chromatogr B Anal Technol Biomed Life Sci 799(1):165–172.
INGA ODENHOLT, ELISABETH LOWDIN, and OTTO CARS, 1997. bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin Clinical Microbiology and Infection, Volume 4, Issue 5, 264 – 270
MAMMAN, P.H., MSHELIA, W.P., and FADIMU, I.E., 2011. Antimicrobial Susceptibility of Aerobic Bacteria and Fungi Isolated from Cases of Equine Ulcerative Lymphangitis in Kano Metropolis, Nigeria. Asian Journal of Animal Sciences, 5: 175-182.
MSHELIA, W.P., ABDUSSAMAD, A.M., ATUMAN, Y.J., SAMBI, S.M., and KWANASHIE, G., 2010. A pictorial review of injuries and disease conditions in foreign and part-barb horses in northern Nigeria: Part I. Res. J. Vet. Sci., 3: 1-12.
PRATT, S.M., SPIER, S.J., CARROLL, S.P., VAUGHAN, P., WHITCOMB, M.B., and WILSON, W.D., 2005. Evaluation of clinical characteristics, diagnostic test results, and outcome in horses with internal infection caused by Corynebacterium pseudotuberculosis: 30 cases (1995-2003). J Amer Vet Med Assoc, 227: 441-448.
SANDY, L., and TIM, S. M., 2012.Corynebacterium pseudotuberculosis: Equine Medicine, Surgery and Reproduction (Second Edition) pg 415.
SCOTT, D.W., and MILLER, W. H., 2003. Equine Dermatology. W.B. Saunders Co., St. Louis. 2003; 90 and 227-232.
SINGATHIA, R., R. MISHRA, R., YADAV, R., GANGIL, P., DUTTA, and LAKHOTIA, R. L., 2011. Therapeutic management of ulcerative lymphangitis in a mare. Haryana Vet. 50: 103-104.
SPIER SJ, 2006. Dryland Distemper - Corynebacterium pseudotuberculosis infections in horses. California Vet, 38: 24-26.
SPIER, S. J. 2019.Corynebacterium pseudotuberculosis infection of horses and Cattle (Pigeon fever, Dry land distemper). In: MSD Veterinary manual. Merck Sharp & Dohme corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
SPIER, S.J., TOTH, B., EDMAN, J., QUAVE, A., and HABASHA, F.,2012. Survival of Corynebacterium pseudotuberculosis biovar equi in soil. The Veterinary Record; London Vol. 170, Iss. 7, (Feb 18, 180. https://doi.org/10.1136/vr.100543
USEH, N. M., OLADELE, S. B., IBRAHIM, N. D.G., NOK, A. J., and ESIEVO, K. A. N., 2005. Prevalence of Equine diseases in Northern Guinea Savannah of Zaria, Nigeria. J. Equine Sci. 16: 27-28.
VALENTINE, B.A., and MCGAVIN, M.D., 2007. Skeletal Muscle. In: Pathologic Basis of Veterinary Diseases, McGavin MD and JF Zachary. Mosby Publisher Inc, St Louis, Missouri, pp: 1010.
ZAVOSHTI, F.R., SIOOFY-KHOJINE, A.B., and MAHPEIKAR, H.A., 2009. A case report of ulcerative lymphangitis (a mini review of causes and current therapies). Turkish Journal of Veterinary Animal Science, 33, 525-528.
View on SCiNiTO
Top